PRKAA1 and ovarian cancer: We next investigated whether targeting AMPK/ACC/FASN-mediated lipogenesis and the AMPK/TAK1/NF-κB signaling cascade suppresses ovarian cancer cell metastasis in vivo using an intraperitoneal xenograft SCID mouse model.